Current results of a phase I study of DKN-01 in combination with paclitaxel (P) in patients (pts) with advanced DKK1+esophageal cancer (EC) or gastro-esophageal junction tumors (GEJ)
Publication
, Conference
Ryan, DP; Murphy, J; Mahalingam, D; Strickler, J; Stein, S; Sirard, C; Landau, S; Bendell, J
Published in: ANNALS OF ONCOLOGY
June 1, 2016
Duke Scholars
Published In
ANNALS OF ONCOLOGY
EISSN
1569-8041
ISSN
0923-7534
Publication Date
June 1, 2016
Volume
27
Start / End Page
108 / 108
Location
Barcelona, SPAIN
Publisher
OXFORD UNIV PRESS
Conference Name
18th World Congress of the European-Society-for-Medical-Oncology (ESMO) on Gastrointestinal Cancer
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Ryan, D. P., Murphy, J., Mahalingam, D., Strickler, J., Stein, S., Sirard, C., … Bendell, J. (2016). Current results of a phase I study of DKN-01 in combination with paclitaxel (P) in patients (pts) with advanced DKK1+esophageal cancer (EC) or gastro-esophageal junction tumors (GEJ). In ANNALS OF ONCOLOGY (Vol. 27, pp. 108–108). Barcelona, SPAIN: OXFORD UNIV PRESS.
Ryan, D. P., J. Murphy, D. Mahalingam, J. Strickler, S. Stein, C. Sirard, S. Landau, and J. Bendell. “Current results of a phase I study of DKN-01 in combination with paclitaxel (P) in patients (pts) with advanced DKK1+esophageal cancer (EC) or gastro-esophageal junction tumors (GEJ).” In ANNALS OF ONCOLOGY, 27:108–108. OXFORD UNIV PRESS, 2016.
Ryan DP, Murphy J, Mahalingam D, Strickler J, Stein S, Sirard C, et al. Current results of a phase I study of DKN-01 in combination with paclitaxel (P) in patients (pts) with advanced DKK1+esophageal cancer (EC) or gastro-esophageal junction tumors (GEJ). In: ANNALS OF ONCOLOGY. OXFORD UNIV PRESS; 2016. p. 108–108.
Ryan, D. P., et al. “Current results of a phase I study of DKN-01 in combination with paclitaxel (P) in patients (pts) with advanced DKK1+esophageal cancer (EC) or gastro-esophageal junction tumors (GEJ).” ANNALS OF ONCOLOGY, vol. 27, OXFORD UNIV PRESS, 2016, pp. 108–108.
Ryan DP, Murphy J, Mahalingam D, Strickler J, Stein S, Sirard C, Landau S, Bendell J. Current results of a phase I study of DKN-01 in combination with paclitaxel (P) in patients (pts) with advanced DKK1+esophageal cancer (EC) or gastro-esophageal junction tumors (GEJ). ANNALS OF ONCOLOGY. OXFORD UNIV PRESS; 2016. p. 108–108.
Published In
ANNALS OF ONCOLOGY
EISSN
1569-8041
ISSN
0923-7534
Publication Date
June 1, 2016
Volume
27
Start / End Page
108 / 108
Location
Barcelona, SPAIN
Publisher
OXFORD UNIV PRESS
Conference Name
18th World Congress of the European-Society-for-Medical-Oncology (ESMO) on Gastrointestinal Cancer
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis